The study finds that despite fears of their over-medicalization, transgender adolescents are only very rarely prescribed ...

The analysis of more than five million children in the US indicates that very few are transgender and prescribed puberty ...

Over the past 15 years, new prescribing of puberty blockers for New Zealand children has increased sevenfold, to a level much ...

A new study found less than .1% of transgender and gender-diverse teens are prescribed puberty blockers or gender-affirming ...

Puberty blockers and gender-affirming hormones are rarely prescribed to U.S. transgender and gender diverse (TGD) adolescents, according to a new study from researchers at Harvard T.H. Chan School of ...

Less than 0.1% of adolescents in the United States identified as transgender or gender diverse and received puberty blockers ...

Among privately insured U.S. adolescents who identified as transgender and gender-diverse (TGD), receipt of puberty blockers ...

On 21 November the Ministry of Health released its long awaited position statement, accompanied by an evidence brief, on the safety and long-term impacts of puberty blockers (a non-medical ...

The use of gender-affirming medical care for trans teens was rare between 2018 to 2022, according to a new study published in ...

The study, which analyzed insurance claims covering more than 5 million patients, provides clearer context as lawmakers ...

Puberty blockers and gender-affirming hormones are rarely prescribed to U.S. transgender and gender diverse (TGD) adolescents ...

Gender-affirming care was rarely provided to minors from 2018 through 2022, according to new research out of Harvard ...